Literature DB >> 18490747

Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression.

Rajkumar Noubade1, Naresha Saligrama, Karen Spach, Roxana Del Rio, Elizabeth P Blankenhorn, Theodoros Kantidakis, Graeme Milligan, Mercedes Rincon, Cory Teuscher.   

Abstract

Structural polymorphisms (L263P, M313V, and S331P) in the third intracellular loop of the murine histamine receptor H(1) (H(1)R) are candidates for Bphs, a shared autoimmune disease locus in experimental allergic encephalomyelitis and experimental allergic orchitis. The P-V-P haplotype is associated with increased disease susceptibility (H(1)R(S)) whereas the L-M-S haplotype is associated with less severe disease (H(1)R(R)). In this study, we show that selective re-expression of the H(1)R(S) allele in T cells fully complements experimental allergic encephalomyelitis susceptibility and the production of disease-associated cytokines while selective re-expression of the H(1)R(R) allele does not. Mechanistically, we show that the two H(1)R alleles exhibit differential cell surface expression and altered intracellular trafficking, with the H(1)R(R) allele being retained within the endoplasmic reticulum. Moreover, we show that all three residues (L-M-S) comprising the H(1)R(R) haplotype are required for altered expression. These data are the first to demonstrate that structural polymorphisms influencing cell surface expression of a G protein-coupled receptor in T cells regulates immune functions and autoimmune disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490747      PMCID: PMC2543130          DOI: 10.4049/jimmunol.180.11.7471

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Drosophila ninaA gene encodes an eye-specific cyclophilin (cyclosporine A binding protein).

Authors:  S Schneuwly; R D Shortridge; D C Larrivee; T Ono; M Ozaki; W L Pak
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Widespread distribution of Gq alpha/G11 alpha detected immunologically by an antipeptide antiserum directed against the predicted C-terminal decapeptide.

Authors:  F M Mitchell; I Mullaney; P P Godfrey; S J Arkinstall; M J Wakelam; G Milligan
Journal:  FEBS Lett       Date:  1991-08-05       Impact factor: 4.124

3.  New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice.

Authors:  R J Butterfield; J D Sudweeks; E P Blankenhorn; R Korngold; J C Marini; J A Todd; R J Roper; C Teuscher
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

4.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.

Authors:  L M McLatchie; N J Fraser; M J Main; A Wise; J Brown; N Thompson; R Solari; M G Lee; S M Foord
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

5.  Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.

Authors:  A B Sparks; N G Hoffman; S J McConnell; D M Fowlkes; B K Kay
Journal:  Nat Biotechnol       Date:  1996-06       Impact factor: 54.908

6.  Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein.

Authors:  N D Dwyer; E R Troemel; P Sengupta; C I Bargmann
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

7.  Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.

Authors:  W A Sewell; J J Munoz; R Scollay; M A Vadas
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

8.  Experimental allergic orchitis in mice. II. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine.

Authors:  C Teuscher
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.

Authors:  W A Sewell; J J Munoz; M A Vadas
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes.

Authors:  D S Linthicum; J A Frelinger
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Expression and trafficking of functional G protein-coupled receptors are related, yet distinct, concepts.

Authors:  Carl M Hurt; Timothy Angelotti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-08       Impact factor: 3.000

2.  Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis.

Authors:  Joseph R Podojil; Mahesh V Padval; Stephen D Miller
Journal:  Cell Immunol       Date:  2011-05-31       Impact factor: 4.868

Review 3.  New developments in the use of histamine and histamine receptors.

Authors:  Craig Smuda; Paul J Bryce
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

4.  Common α2A and α2C adrenergic receptor polymorphisms do not affect plasma membrane trafficking.

Authors:  Carl M Hurt; Matt W Sorensen; Timothy Angelotti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-19       Impact factor: 3.000

5.  Treatment with anti-FcεRIα antibody exacerbates EAE and T-cell immunity against myelin.

Authors:  Silvia Musio; Massimo Costanza; Pietro Luigi Poliani; Elena Fontana; Manuela Cominelli; Gabriella Abolafio; Lawrence Steinman; Rosetta Pedotti
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-04-14

6.  Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.

Authors:  Dimitry N Krementsov; Emma H Wall; Rebecca A Martin; Meenakumari Subramanian; Rajkumar Noubade; Roxana Del Rio; Gary M Mawe; Jeffrey P Bond; Matthew E Poynter; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.